Quick Takeaways
- PRIMECAP MANAGEMENT CO/CA/ filed SCHEDULE 13G/A for BioMarin Pharmaceutical Inc. COM (BMRN).
- Disclosed ownership: 8.2%.
- Date of event: 30 Jun 2025.
PRIMECAP MANAGEMENT CO/CA/ - 30 Jun 2025 SCHEDULE 13G/A Report for BioMarin Pharmaceutical Inc. COM (BMRN)
- Filing Manager
- PRIMECAP MANAGEMENT CO/CA/
- Reporting Manager
- PRIMECAP MANAGEMENT CO/CA/
- Security
- BioMarin Pharmaceutical Inc. COM
- Symbol
- BMRN
- Shares outstanding
- 191,691,541 shares
- Disclosed Ownership
- 15,795,383 shares
- Ownership
- 8.2%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Aug 2025, 12:43:58 UTC
- Date of event
- 30 Jun 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"PRIMECAP MANAGEMENT CO/CA/ disclosed 8.2% ownership in BioMarin Pharmaceutical Inc. COM (BMRN) on 30 Jun 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Aug 2025, 12:43.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| PRIMECAP MANAGEMENT CO/CA/ | 8.2% | 15,795,383 | 15,087,400 | 0 | Jorge A. Rodriguez | Deputy Chief Compliance Officer |